GLP-1 receptor agonist medications have been proven in clinical studies to cause permanent blindness from NAION.

While some observational studies and retrospective cohort reviews have suggested a potential link between GLP-1 receptor agonist medications and non-arteritic anterior ischemic optic neuropathy, leading medical organizations stress that causation has not been proven. Major groups, including the American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society, have issued consensus statements pointing out that available observational data indicate a possible small relative risk increase, but randomized controlled trials and broader meta-analyses have generally not established a definitive causal relationship.nanosweb.orgnanosweb.orgSemaglutide and NAION 08212024.pdfCausation Has Not Been Established: The consensus highlights that while initial retrospective studies (notably originating from a 2024 Harvard/Mass Eye and Ear cohort study) Causation Has Not Been Established: The consensus highlights that...retinarocks.orgretinarocks.orgGlucagon Like Peptide 1 Receptor Agonists and the Risk of Non Arteritic Anterior...Title and Publication Details Document Title: Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the...

Regulatory bodies such as the U.S. Food and Drug Administration have monitored the issue as a potential safety signal, and some international regulators have reviewed product labeling, yet clinical experts maintain that more definitive research is required to confirm whether the drugs directly cause the condition.aao.orgaao.orgGlucagon Like Peptide 1 Receptor Agonists Risk ofIt typically causes sudden, painless, and often permanent vision loss or blindness in one eye While overall incidence in the general population is low (roughly 2.3 to 10.2 per 100,000) While overall incidence in the general population is... Although NAION itself is a serious condition that can result in permanent vision loss, framing it as a proven consequence of GLP-1 therapy overstates what current clinical and scientific literature has established.drugs.comdrugs.comCan Ozempic and Wegovy cause eye blindness?While observational studies have identified a potential association between GLP-1 receptor agonists (such as semaglutide and tirzepatide) and a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION), causation...+2 more